BioSyent Inc. (TSXV:RX)
Canada flag Canada · Delayed Price · Currency is CAD
14.41
-0.19 (-1.30%)
Apr 7, 2026, 2:54 PM EST

BioSyent Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
43.0535.0331.5927.9328.62
Revenue Growth (YoY)
22.90%10.89%13.13%-2.42%28.15%
Cost of Revenue
10.097.175.995.075.98
Gross Profit
32.9627.8625.622.8622.64
Selling, General & Admin
21.2118.8518.0115.7814.34
Research & Development
0.560.250.120.10.12
Total Operating Expenses
21.7719.118.1315.8814.45
Operating Income
11.198.757.476.988.18
Interest Income
-0.89-1.09-1.13-0.53-0.16
Interest Expense
0.050.060.070.080.09
Other Non-Operating Income (Expense)
----0.13
Total Non-Operating Income (Expense)
-0.84-1.03-1.06-0.450.05
Pretax Income
12.039.788.537.438.38
Provision for Income Taxes
3.022.512.071.972.1
Net Income
9.017.276.465.466.28
Net Income to Common
9.017.276.465.466.28
Net Income Growth
23.96%12.54%18.35%-13.11%65.51%
Shares Outstanding (Basic)
1112121213
Shares Outstanding (Diluted)
1212121313
Shares Change (YoY)
-2.55%-2.98%-2.95%-2.57%-1.70%
EPS (Basic)
0.800.630.540.440.49
EPS (Diluted)
0.780.620.530.430.49
EPS Growth
27.11%16.01%22.07%-10.86%68.28%
Shares Outstanding
11.2611.2811.7412.112.56
Free Cash Flow
8.968.6254.94.59
Free Cash Flow Growth
3.87%72.58%1.91%6.79%-33.29%
Free Cash Flow Per Share
0.780.730.410.390.36
Dividends Per Share
0.2000.1800.1600.040-
Dividend Growth
11.11%12.50%300.00%--
Gross Margin
76.57%79.52%81.03%81.85%79.10%
Operating Margin
26.00%24.99%23.65%25.00%28.59%
Profit Margin
20.93%20.75%20.45%19.55%21.95%
FCF Margin
20.80%24.61%15.81%17.55%16.04%
EBITDA
12.059.347.937.438.64
EBITDA Margin
27.98%26.67%25.09%26.62%30.19%
EBIT
11.198.757.476.988.18
EBIT Margin
26.00%24.99%23.65%25.00%28.59%
Effective Tax Rate
25.09%25.68%24.30%26.54%25.03%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.